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Abstract
CKD (Chronic Kidney Disease) and other chronic diseases were potential to prevalence
of hospital malnutrition and caused financial burden. In CKD stage 5 performed dialysis,
malnutrition increased with hypercatabolic related to disease progression or nutritional
disorders during dialysis, and psychosocial issues such as depression and economic
factors. Inadequacy of dialysis treatment might be an important cause of malnutrition.
This study aimed to describe association between length of hemodialysis period,
diabetic comorbidity, and adequacy of hemodialysis to the changes of SGA (Subjective
Global Asessment) score on HD patients at RSIJ CP hospital on February and July 2017.
This was a cohort retrospective study used secondary data from medical record and
nutritional status screening report. Data from a total of 90 maintenance hemodialysis
patients participated on this study. The inclusion criteria were being on HD for at least
three month, upper 15th years old, having complete data such as social demographic,
date of HD initiating, medical diagnosis, the Qb rate, dry body weight, and HD duration
of eight-time HD on last observasion, SGA score and BMI (Body Mass Index) on two
period (February and July 2017). There was no significant differences between the
changes of SGA score to demographic variables, except to marietal status (p=0.003).
There was no significant differences between the changes of SGA score to the length
of HD period (p = 0.527), and to adequacy of hemodialysis (p = 0.484). exception to
Diabetic comorbidity (p = 0.043). There was 73.7 % of patients with HD period > 2
years had no improvement of SGA score. There was a younger tendency in increased
SGA score group (worsening) than in decreased SGA score group (48.8 + 15.4 vs
55.9 + 10.4 years), meanwhile 64.4% of patients were maintenance HD patients under
2 years periode. Increased prevalence of HD patients with worsening SGA score in
younger patients which period of HD < 2 years was sign for better monitoring program
and nutrition intervention. Further studies needed for correlation and regression to
get dominant variables as determinant of nutritional status changes so appropriate
nutritional intervention program could be delivered to improve quality of life of HD
patients.
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1. Introduction
A systematic review of 26 studies (2003 – 2006) showed that prevalence of Chronic
Kidney Diseases (CKD) in the USA was 7.2% in persons aged 30 years or older, whereas
in population aged 64 years or older, prevalence of CKD varied from 23.4% to 35.8%
(Zhang and Rothenbacher, 2008). Data from CIHI (Canadian Institute for Health Informa-
tion) in 2010 indicated that CKD prevalence in Canada increased by 20% from 1999 to
2008 (5,431 patients in 2008), with 76% - 78% of them had received initial HD treatment.
Early treatment seemed to show a good response at the population level that the annual
rate growth in the prevalence of CKD decreased from 4.5% (for HD 6.1%) in 2000 to -1.4%
(for HD -2.3%) in 2008 (Fortin, C. M. et al., 2010).
The average incidence figure was reported to be around 200 cases per million per
year in many countries. In the USA, Taiwan, and some regions in Mexico, the number
approached 400 cases per million and had risen faster in the older population. Dialysis
is the main method of applied for CKD in most countries with an average survival of 3–5
years in the USA, prevalence nears to 1800 cases per million. In Japan and Taiwan, high
survival rate translates to high prevalence approach 2400 cases per million (Levey and
Coresh, 2012). Indonesian Renal Registry (2012) reported that CKD incidents with the HD
treatment increased by 294,3% (from 4.977 patients in 2007 to 19.621 patients in 2012).
Also, National Health Insurance (JKN) data in 2015 revealed that 23.9% of the cost of
health services was spent finance catastrophic diseases and CKD disease ranks second
after heart disease. Similarly, the number of CKD cases had been increasing in the
United States, and with increasing prevalence, it was predicted that by 2010, there were
almost 700,000 dialysis patients in the United States, costing about US$30million a year
for their dialysis treatment. Treatment of such an ever-increasing burden of end-stage
kidney failure could not be afforded, even in the wealthiest of countries (Atkins, 2005).
In addition to the HD treatment cost itself, there is a hidden cost associated with
cases of CKD on HD treatments, among which is a cost associated with malnutrition.
Assessment for the hospital financial cost caused by undiagnosed or undocumented
cases of malnutrition has been done in some studies, by using SGA (Subjective Global
Assessment) as an instrument to assess the risk of malnutrition. With this technique, it
was found that in Brisbane financial loss was AUD 1,677,235 annually, while inMelbourne
it was estimated that the deficit to the hospital in reimbursements was of AUD 1,850,540
annually. In Germany, the annual financial shortfall is found to be €35,280. Similarly, the
USA reported a loss of more than USD 86,000 after conducting a retrospective audit of
patient medical charts [6].
In CKD stage 5 patient who underwent dialysis, their risk of malnutrition increased due
to the hyper-catabolic state associated with disease progression or nutritional disorders
during dialysis, and further compound by psychosocial issues such as depression and
economic factors. Nutritional problems in adult patients with stage 5 CKD on dialysis
could be classified into three categories: protein-energy wasting (PEW), obesity and dia-
betes. PEW in dialysis is related to inadequate food intake, abnormal nutrientmetabolism
(primarily in amino acids metabolism), residual renal function and dialysis dose (Heng
and Cano, 2009).
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Some studies reported a positive correlation between the adequacy of hemodialysis
and subjective global assessment of nutritional status. The inadequacy of dialysis treat-
ment might be an important cause of malnutrition (Locatelli et al., 2002). Kidney Disease
OutcomesQuality Initiative (KDOQI) Guideline for Hemodialysis Adequacy (2015) recom-
mended a single target pool Kt/V (spKt/V) of 1.8 per hemodialysis session for patients
treated thrice weekly, with a minimum delivered spKt/V of 1.2 and the Urea Reduction
Ratio (URR) minimum 65%. Good general and nutritional condition were some of the
clinical criteria of adequate dialysis (N.K. Man, et al, 1995). Urea reduction was found to
be a predictor factor for patient’s appetite.
2. Materials dan Methods
The study employed a cohort retrospective design and descriptive, analytical study,
utilizing secondary data from the medical record and nutritional status screening report.
The inclusion criteria were 1) patients on HD at the HD Outpatient Unit in Rumah Sakit
Islam Jakarta Cempaka Putih (RSIJ CP) for at least three months, 2) aged above 15th
years, 3) complete data could be found in their medical records for their: social demo-
graphic (age, gender, marital status, employee status, and education), date of HD initiat-
ing, medical diagnosis, theQb (Quick of blood) rate, dry bodyweight, SGA score and BMI
(Body Mass Index), and 4) having completed eight HD treatments between the selected
time frame (February and July period in 2017).
A total of 136 CKD patients on maintenance hemodialysis for at least three months
were selected from the Hemodialysis Outpatient Unit at RSIJ CP during February and
July 2017. From theses, patients who have nutritional assessment between February
2017 and July 2017 are the population study. Patients were excluded if passed away
(n=3), couldn’t be measured for SGA and BMI or with missing data (n = 40) and were
HD transfer to another HD unit (n = 3). Thus, data from 90 patients were collected in
the study. SGA and BMI data were collected from nutritional status screening report in
Nutrition Department of RSIJ CP Hospital. The date of HD initiating, medical diagnosis
to assess the presence of Diabetic comorbidity, the Qb rate, dry body weight and HD
duration of eight-time HD on July 2017 were collected from medical records of each
maintenance hemodialysis patient. Descriptive and analytical statistics were carried out
to analyze the data.
3. Results
Patients characteristic from demographic data are shown in Table 1. The study popu-
lation had a lower proportion of male patients (48.89%); a stark difference from other
studies which usually have a higher proportion of male patients. The subjects had a
mean age of 52.17 ± 12.6 years (CI 95%, 49.53 – 54.81), the major education of patients
was high school (51.65%), 85.56%of patients hadmarried, and 58.89%was unemployed.
Based on HD history, 57.78% of patients had a length of HD under two years and 73.33%
of patients without Diabetic comorbidity.
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Table 1: Patients Characteristic.
Characteristic Mean ± SD Min -Max 95% CI n %
Age (years) 52.17 ± 12.6 19 - 82 49.53 – 54.81 90
Adequacy HD (Kt/V) 2.11 ± 0.39 1.33 – 3.37 2.033 – 2.197 87
Gender, Male 44 48.89
Education, Elementary 25 27.47




Length oh HD, > 2 years 38 42.22
Comorbidities, Diabetes 24 26.67




Comparison of BMI on two periods with T-test was resulting in no significant differ-
ences of BMI on first period (February) and the second period ( July) with p-value = 0.073,
but the mean of BMI on the first period was still higher than the second period (23,4 +
3.7 vs. 22.8 ± 3.30). Similarly, differences mean of SGA score on the first period and the
second period had no significant (p-value = 0.535). Based on One Way ANOVA test to
the difference mean of age, there was no significant difference (p = 0.415) in all three
groups of SGA score changes. The observation period of 132 days in this study and the
number of samples might not be able to show significant change. It seemed to look
like HEMO Study which involved 893 maintenance HD patients had no significant in the
difference of BMI and SGA score after three years of observation. (Rocco et al., 2004).
Statistical test with chi-square showedno significant differences of SGA score changes
to gender groups (p-value = 0.734), either to the level of education (p=0.736) and
to employee status too (p-value 0.951). It was only to marital status which showed a
significant difference (p=0.003). We found 61 patients (79.2%) with unchanged SGA
score who had married and five patients (71.4%) with increasing SGA score (worsening)
from the unmarried group.
Again, there was no significant differences of SGA score changes to the length of HD
period< 2 years and> 2 years (p = 0.527), to three groups of BMI changes (p= 0.918), and
to adequacy of hemodialysis with p-value 0.484 but there was significant differences of
SGA score changes to Diabetic comorbidity (p = 0.043). The results were as showed at
Table 2.
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Table 2: Statistical Tests of Association SGA Score Changes With All Independent Variables.
Variables SGA Score Changes Total p-value*
Decreased Unchanged Increased
n % n % n % n %
1 Age (years) 0.415
Mean 55.9 52.0 48.8
SD 10.4 12.3 15.4
2 Gender 0.734
Female 5 10.9 33 71.7 8 17.4 46 100
Male 5 11.4 34 77.3 5 11.4 44 100
Total 10 11.1 67 74.4 13 14.4 90 100
3 Education 0.736
Elementary 1 4.0 20 80.0 4 16.0 25 100
High School 7 14.9 33 70.2 7 14.9 47 100
College 2 11.1 14 77.8 2 11.1 18 100
Total 10 11.1 67 74.4 13 14.4 90 100
4 Marital Status 0.003
Unmarried 0 0.0 2 28.6 5 71.4 7 100
Married 9 11.7 61 79.2 7 9.1 77 100
Widow/Widower 1 16.7 4 66.7 1 16.7 6 100
Total 10 11.0 67 74.4 13 14.4 90 100
5 Employee Status
Unemployee 6 11.3 38 71.7 9 17 53 100 0.951
Student 0 0.0 3 100.0 0 0.0 3 100
Employee 4 11.4 26 77.1 4 11.4 34 100
Total 10 11.1 67 74.4 13 14.4 90 100
6 Length of HD Period
< 2 years 7 13.5 39 75.0 6 11.5 53 100 0.527
> 2 years 3 7.9 28 73.7 7 18.4 38 100
Total 10 11.1 67 74.4 13 14.4 90 100
7 BMI Changes
Decreased 5 10.6 35 74.5 7 14.9 47 100 0.918
Unchanged 0 0.0 3 75.0 1 25.0 4 100
Increased 5 12.8 29 74.4 5 12.8 39 100
Total 10 11.1 67 74.4 13 14.4 90 100
8 Diabetic comorbidity
Yes 6 25 16 66.7 2 8.3 24 100 0.043
No 4 6.1 51 77.3 11 16.7 66 100
Total 10 11.1 67 74.4 13 14.4 90 100
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Variables SGA Score Changes Total p-value*
Decreased Unchanged Increased
9 Adequacy of HD (Kt/V)
< 1.8 1 4.8 18 85.7 2 9.5 21 100 0.484
> 1.8 8 12.1 47 71.2 11 16.7 67 100
Total 9 10.3 65 74.7 13 14.9 87 100
*= p-value for all statistical test used chi-square test except for Age used oneway ANOVA test
4. Discussion
Nutritional status characteristics of patients were majority tend to decrease even though
SGA score has not been changed yet. It could be shown in unchanged SGA score group,
it was 74.5% of patients experienced decreasing of BMI, and in increased SGA score
group (worsening), it was 14.9% of patients experienced decreasing of BMI. Related to
the length of the HD period, it tended to the longer the period of HD the more likely to
have to decrease on BMI. It was found 73.7 % of patients with HD period > 2 years had
no improvement of SGA score and higher number patients with increased SGA score
(worsening) in HD period > 2 years group than in < 2 years group (18.4% vs. 11.5%).
It could be considered that PEW compromising middle-term survival is found in ∼25%
of maintenance dialysis patients (Heng and Cano, 2009). PEW was a consequent for
HD patients either was caused deteriorating nutrition intake (loss of appetite, anorexia,
or protein restriction before HD initials), increasing of nutritional needs (were caused
increasing REE (Resting Energy Expenditure) related to inflammation and severe hyper-
parathyroidism) or loss of nutrients during dialysis. Amino acid and protein losses during
the dialysis session, together with low nutrient intake, promote low nutrient availability
for muscle synthesis (Lofberg E, 2000 in Carrero, 2013). In dialysis patients, PEW at
baseline assessed with SGA was associated with 2-fold increased mortality risk in 7
years of follow-up (Mutsert et al., 2009).
The SGA has been found to be reliable and valid for assessing PEW in HD patients.
A single SGA assessment has been shown to be associated with morbidity, hospitaliza-
tion, and mortality in several clinical studies. Therefore, since 2000 the National Kidney
Foundation Kidney Disease/Dialysis Outcomes and Quality Initiative (NKF K/DOQI) has
recommended the use of the SGA for assessing the nutritional status of dialysis patients.
SGAmay validly distinguish different degrees of PEW associated with increasing risks of
mortality and recommended shorten interval on monitoring of unstable and malnutrition
patients (Mutsert et al., 2009).
Severe PEW in HD patients was very difficult to overcome. Provision of nutritional sup-
plements (high energy emulsions, LCT (Long Chain Triglyceride) with vitamins and min-
erals) in hemodialysis patients with high SGA scores (poor) found there was no change in
BMI or change in SGA score (Chan, et al., 2014). Severe malnutrition requiring nutritional
intervention can be diagnosed by a decrease in BMI < 20, a body weight loss > 10%
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within six months, serum albumin <35 g/l and transthyretin <300 mg/l (Heng and Cano,
2010).
The presence of diabetic comorbidity factor was a risk factor for the cause of death in
hemodialysis patients. The cumulative survival of the poor A1C group during the survey
was significantly lower than that of the fair and good A1C groups (p = 0.041). In diabetic
CKD patients on regular hemodialysis, poor glycemic control was an independent pre-
dictor of prognosis (Oomichi et al., 2006). Ali et al. (2017) found a poor quality of life on
56.7% of HD patients with diabetic comorbidity (p = 0.0001).
In this study, there was a significant association between diabetic comorbidity and
SGA score changes (p = 0.043), but it seemed negative correlations. We found there
was a 2 – fold proportion of patients with no diabetic comorbidity in increased SGA score
group (worsening) compared with proportion of patients with diabetic comorbidity (16.7%
vs. 8%). Similarly, there was a 4 – fold proportion of patients with diabetic comorbidity
in decreased SGA score group (improved) compared with the proportion of patients
with no diabetic comorbidity (25% vs. 6.1%). This phenomenon was likely influenced
by other variables that were not studied in this study such as nutrient intake factor
influenced to nutritional status and blood glucose or HbA1c factor described glycemic
control of Diabetes. Even in diabetic CKD patients undergoing regular hemodialysis,
good glycemic control is an independent predictor of prognosis even after adjustment
for known classical factors (Oomichi et al., 2006).
Another phenomenon when viewed mean distribution of age, there was a younger
tendency in increased SGA score group (worsening) than in decreased SGA score group
(48.8 ± 15.4 vs. 55.9 ± 10.4 years); meanwhile 64.4% of all patients were maintenance
HD patients with HD period < 2 years. Patients might be anorectic during the weeks or
months preceding the start of dialysis, particularly if they were under-managed. Patients
might not want to change their whole behavior, including food habits (Locatelli et al.
2002). This phenomenon will be more revealed when the data of nutrient intake was
available.
Also, this phenomenon alsomight be the impact of increased access to CKD treatment
stage 5 conducted by the government through universal coverage (BPJS). As in Canada
(2008), there were 5431 new patients diagnosed with CKD increased 20% from 1999,
and 76% - 78% of them treated HD. Public response was quite good with early treatment
so that an increase in the prevalence of CKD per year decline from 4.5% (for HD 6.1%)
in 2000 to -1.4% (for HD -2.3%) in 2008 (Fortin, C. M. et al., 2010). This was also an
indication of the increasing prevalence of CKD stage 5 at a younger age with poor SGA
condition. Efforts to improve the nutritional status during the early days of hemodialysis
was a potential program to maintain the survival of younger patients.
Based on the mean of the adequacy of HD (Kt/V), 21 patients (23.9%) had inadequate
HD (Kt/V< 1.8). The data showed a higher number of patients with decreased SGA score
(improve) inadequate HD group compared with the number of patients in the inadequate
HD group (12.1% vs. 4.8%. This seemed consistent with studies that prove the adequacy
of hemodialysis affected the nutritional status of patients. But we found there was still
a higher proportion of patients with increased SGA score (worsening) inadequate HD
group compared with the proportion of patients in the inadequate HD group (16.7% vs.
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9.5%). This study took only eight sessions of HD data for Kt/V in the last observation. It
might be not enough to describe all adequacyHDprocess to influence SGA score.When
adequacy targets were met in hemodialyzed patients, survival was mainly dependent on
age and nutritional status (Combe et al., 2001). Criteria of adequacy were predictors of
mortality and morbidity, both on CAPD and HD, whereas normalized protein catabolic
rate and subjective global assessment of nutritional status were not (Maiorca et al., 1995).
Prior studies using the ADAT (Appetite and Diet Assessment Tool) have demonstrated
an association between increasing appetite assessment scores and increasing protein
and energy intake in adequate HD patients. Adequate dialysis (at present a Kt/V >1.2
for HD) should be provided. Whether a higher Kt/V could improve nutritional status was
not established at present (Locatelli et al., 2002). Good general and nutritional condition
were some of the clinical criteria of adequate dialysis (N.K. Man et al., 1995). Urea reduc-
tion was predictor factor for influencing patient’s appetite. In this study, 76% of patients
were on adequate HD but the proportion of increased SGA score (worsening) still higher
than inadequate HD group. It seemed that the process of improving SGA score was
slower than the process of the adequacy of HD. Another reasonwas adequacy of dialysis
had focused on the removal of organic compounds such as urea. Hemodialysis mainly
works on the principle of diffusion in which the substances with a lower concentration
in dialysate than in blood to be removed by dialysis. This leads to depletion of many
important inorganic substances such as phosphor and zinc which contributed to energy
metabolism. Poor nutrition intake would be worsening this condition. Fortunately, the
nutrition intake data was not available in this study. Again, there were some limitations
for this study to measure appetite led to protein intake that could be correlated with the
adequacy of HD.
5. Conclusions and Recommendations
The increased prevalence of HD patients with increased SGA score (worsening) espe-
cially in younger patients and the period of HDunder two yearswas a sign for the require-
ment of the better monitoring program and nutrition improvement. Larger sample size
and longer observation period and observation of variables such as nutritional intake,
periodical measurement of adequate Kt/V, measurement of appetite appraisal score,
blood glucose examination or HbA1C related to glycemic control in diabetic comorbidity
were needed to obtain a more significant change in nutritional status and the dominant
influenced variables. For further studies, it was needed to get a deeper correlation
and regression to see the dominant determinant variables in nutritional status changes
which impact onmortality and quality of life of patients. Monitoring program and nutrition
improvement of HD patients had a chance for survival of younger patients.
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